AKT活性の阻害剤 - MERCK & COMPANY INCOPORATED

Title:

AKT活性の阻害剤

Document Type and Number:

Japanese Patent JP4394959

Kind Code:

B2

Abstract:

The compounds of Formula E are useful as anti-cancer agents:

More Like This:

WO/2018/035359	THERAPEUTIC COMPOUNDS USEFUL FOR THE PROPHYLACTIC OR THERAPEUTIC TREATMENT OF AN HIV VIRUS INFECTION
JP2009532405	Substituted phenylpiperidine derivative as melanocortin-4 receptor regulator
JP4823914	Inhibition of FGFR3 and treatment of multiple myeloma

Inventors:

Mark Gun, Dagan
Linsley, Craig Davryu
Chiao, Chichiyan

Application Number:

JP2003583306A

Publication Date:

January 06, 2010

Filing Date:

April 04, 2003

Export Citation:

Assignee:

MERCK & COMPANY INCOPORATED

International Classes:

C07D401/14; A61K31/497; A61K45/00; A61P35/00; A61P43/00; C07D241/18

Domestic Patent References:

Other References:

VENUGOPALAN, B., et al.,Eur. J. Med. Chem.,24(6),pp.611-614 (1989)

Attorney, Agent or Firm:

Yoshio Kawaguchi
Akio Ichiiri
Makoto Ono
Katsuma Osaki
Mitsuaki Tsubokura

Previous Patent: ビデオシーケンス内における後方動きベクトルの推定方法

Next Patent: Ａｋｔ活性阻害薬